Cell Therapy Instruments Market for Consumables by Product Segments is Expected to Grow at Highest CAGR During 2020-2027
According to this new market research study on “Cell Therapy Instruments Market to 2027 - Global Analysis and Forecast - by Product, Cell Type, Process, and End User” the market is expected to reach US$ 32,477.15 million by 2027 from US$ 12,340.03 million in 2019. The market is estimated to grow with a CAGR of 13.2% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. The key driving growth factors for the market include increasing developments in cell therapy manufacturing and rising number of approvals for cell-based therapies; whereas, high cost of cell therapy production and cell therapy are expected to hinder market growth.
Based on the product, the cell therapy instruments market is segmented into consumables, equipment, systems, and software. In 2019, the consumables segment accounted for the highest share of the market. The growth of this segment is attributed to the rising research activities that demand reagents, kits, and lab wares in higher quantity. Also, the increased production of cell therapies for commercialization has influenced the market for the consumables segments. Additionally, the rising adoption of cell therapy has increased the demand for storage consumables to supply and distribute it to the desired places.
Thermo Fisher Scientific Inc.; MERCK KGaA; Lonza; Cytiva (GE Healthcare Life Sciences); Terumo Corporation; BD; Miltenyi Biotec; STEMCELL Technologies Inc.; Sartorius AG; and Danaher Corporation (Beckman Coulter Inc.) are among the leading companies operating in the cell therapy instruments market. The companies have adopted inorganic and organic growth strategies to expand their global footprints, and product portfolio to meet the rising demand for the cell therapy products and services. For instance, in March 2019, Thermo Fisher Scientific Inc. acquired Brammer Bio, to expand the capabilities of Thermo Fisher Scientific Inc. to support high-growth in cell therapy market.
The report segments global cell therapy instruments market as follows:
By Product
By Cell Type
By Process
By End User
By Geography
North America
Europe
Asia Pacific (APAC)
Middle East and Africa (MEA)
Reasons to Buy
According to this new market research study on “Cell Therapy Instruments Market to 2027 - Global Analysis and Forecast - by Product, Cell Type, Process, and End User” the market is expected to reach US$ 32,477.15 million by 2027 from US$ 12,340.03 million in 2019. The market is estimated to grow with a CAGR of 13.2% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. The key driving growth factors for the market include increasing developments in cell therapy manufacturing and rising number of approvals for cell-based therapies; whereas, high cost of cell therapy production and cell therapy are expected to hinder market growth.
Based on the product, the cell therapy instruments market is segmented into consumables, equipment, systems, and software. In 2019, the consumables segment accounted for the highest share of the market. The growth of this segment is attributed to the rising research activities that demand reagents, kits, and lab wares in higher quantity. Also, the increased production of cell therapies for commercialization has influenced the market for the consumables segments. Additionally, the rising adoption of cell therapy has increased the demand for storage consumables to supply and distribute it to the desired places.
Thermo Fisher Scientific Inc.; MERCK KGaA; Lonza; Cytiva (GE Healthcare Life Sciences); Terumo Corporation; BD; Miltenyi Biotec; STEMCELL Technologies Inc.; Sartorius AG; and Danaher Corporation (Beckman Coulter Inc.) are among the leading companies operating in the cell therapy instruments market. The companies have adopted inorganic and organic growth strategies to expand their global footprints, and product portfolio to meet the rising demand for the cell therapy products and services. For instance, in March 2019, Thermo Fisher Scientific Inc. acquired Brammer Bio, to expand the capabilities of Thermo Fisher Scientific Inc. to support high-growth in cell therapy market.
The report segments global cell therapy instruments market as follows:
By Product
- Consumables
- Equipment
- Single-Use Equipment
- Cell Processing Equipment
- Other Equipment
- Systems and Software
By Cell Type
- Human Cells
- Differentiated Cells
- Stem Cells
- Animal Cells
By Process
- Cell Processing
- Process Monitoring and Quality Control
- Cell Preservation, Distribution, and Handling
By End User
- Research Institutes
- Life Science Research Companies
- Other End Users
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- UK
- Spain
- Italy
Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- South and Central America (SCAM)
- Brazil
- Argentina
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell therapy instruments market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global cell therapy instruments market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction
3. Research Methodology
4. Global Cell Therapy Instruments- Market Landscape
5. Cell Therapy Instruments Market - Key Market Dynamics
6. Cell Therapy Instruments Market - Global Analysis
7. Cell Therapy Instruments Market Analysis - By Product
8. Cell Therapy Instruments Market Analysis - By Cell Type
9. Cell Therapy Instruments Market Analysis - By Process
10. Cell Therapy Instruments Market Analysis - By End User
11. Cell Therapy Instruments Market Analysis And Forecast To 2027 - Geographical Analysis
12. Impact of COVID-19 Pandemic on Global Cell Therapy Instruments Market
13. Industry Landscape
14. Company Profiles
15. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc.
- MERCK KGaA
- Lonza
- Cytiva (GE Healthcare Life Sciences)
- Terumo Corporation
- BD
- Miltenyi Biotec
- STEMCELL Technologies Inc.
- Sartorius AG
- Danaher Corporation (Beckman Coulter Inc.)